Why Grail Shares Are Plummeting
Source: Motley Fool
2026-02-23 16:15:00 ET
Shares of cancer-detection firm Grail (NASDAQ: GRAL) fell by half in last Friday's trading session. That's quite a turnabout after the company's share price more than quintupled in 2025, from about $19 a share in January to $110 in November.
Last week shares of the California-based biotech were trading at around $102. Today they're priced at $49. What happened?
Image source: Getty Images.
GRAIL Inc.
NASDAQ: GRAL
GRAL Trading
-4.34% G/L:
$42.28 Last:
892,349 Volume:
$43.44 Open:
GRAL Latest News
March 12, 2026 04:30:00 pm
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
March 11, 2026 07:20:00 am
Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity
GRAL Stock Data
$4,041,676,881
35,687,321
0.29%
174
N/A
Medical Diagnostics & Screening
Healthcare
US
Menlo Park
